F-star Therapeutics, Inc.
USD7.12
+0.00 (+0.00%)
CEO
Eliot Richard Forster
IPO Date
2021-05-07
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
GB
Open
$7.11
Prev. Close
$7.12
Day Low
$7.11
Day High
$7.12
52W Low
$2.07
52W High
$7.12
Market Cap
$0.16B
| -2.5 |
| 31 Dec 2019 | FY | 100.0% | -81.3% | -269.6% | -59.8% | 1.82 | 0.64 | -2.8 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | -40.9% | -33.4% | 0.00 | 11.61 | -4.6 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | -79.7% | -53.4% | 0.00 | 11.53 | -2.9 |
| 31 Dec 2016 | FY | 0.0% | 0.0% | -102.0% | -66.6% | 0.00 | 7.30 | -3.0 |
| -1.8 |
| 31 Mar 2022 | Q1 | 100.0% | -476.1% | -13.8% | -10.6% | 0.15 | 6.11 | -1.5 |
| 31 Dec 2021 | Q4 | 100.0% | 27.1% | 4.9% | 3.9% | 0.14 | 6.98 | 5.5 |
| 30 Sept 2021 | Q3 | 100.0% | -1436.9% | -12.0% | -9.4% | 0.15 | 8.62 | -3.5 |
| 30 Jun 2021 | Q2 | 0.0% | 0.0% | -15.8% | -12.5% | 0.14 | 8.57 | -2.3 |
| 31 Mar 2021 | Q1 | 100.0% | -338.3% | -28.3% | -18.5% | 0.12 | 0.96 | -1.6 |
| 31 Dec 2020 | Q4 | 100.0% | -5243.6% | -19.9% | -13.4% | 0.07 | 1.54 | -1.9 |
| 30 Sept 2020 | Q3 | 100.0% | -37.5% | -18.8% | -10.0% | 0.16 | 3.62 | -4.7 |
| 30 Jun 2020 | Q2 | 100.0% | -1190.1% | -27.8% | -20.9% | 0.13 | 5.11 | -2.5 |